Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · May 15, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how primary open-angle glaucoma (POAG), a common eye condition that can gradually reduce vision, affects the ability of older adults to move around and participate in daily activities. Researchers want to understand if people with POAG have more difficulty navigating their environment, especially in low-light conditions, compared to those without eye diseases. The goal is to learn more about the relationship between vision loss and mobility to help improve care for individuals with this condition.

To participate in the trial, you need to be between 65 and 85 years old and enrolled in specific ongoing studies related to glaucoma. If you're healthy and have no eye disease, you may also be eligible to join as a control participant. Those taking part can expect to undergo tests that will assess their mobility and how well they can move in different lighting situations. Overall, this study aims to shed light on the challenges faced by older adults with glaucoma and improve their quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria (Patients):
• • Participants that are enrolled in the Early Detection of Glaucoma Progression using a Novel Individualized Approach (IRB-300000301) or in the African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression (IRB-161115004).
• Exclusion Criteria (Patients):
• • Not being enrolled in one of the following two NIH-funded studies: 1. African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the lamina cribrosa in progression (EY026574) or 2. Early detection of glaucoma progression using a novel individualized approach (EY025756)
• Inclusion Criteria (Controls):
• • No diagnosis of eye disease
• Exclusion Criteria (Controls):
• • Cognitive impairment that would preclude ability to take the tests